Palacios Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$483K Sell
20,078
-484
-2% -$12.7K 0.29% 47
2026
Q1
$549K Buy
20,562
+9,012
+78% +$240K 0.34% 43
2025
Q4
$288K Sell
11,550
-12,142
-51% -$306K 0.22% 54
2025
Q3
$604K Buy
23,692
+3,223
+16% +$79.5K 0.4% 41
2025
Q2
$496K Sell
20,469
-236,422
-92% -$5.51M 0.41% 41
2025
Q1
$25.6M Buy
256,891
+235,417
+1,096% +$6.16M 19.04% 2
2024
Q4
$569K Buy
+21,474
New +$582K 0.61% 33

Other funds holding PFE

Palacios Wealth Management's PFE Position: Q2 2026 in Review

Palacios Wealth Management reduced its Pfizer (PFE) stake by 2.4% in Q2 2026, selling an estimated $12.7K and leaving 20,078 shares worth $483K. The position accounts for 0.29% of the portfolio, ranked #47.

Palacios Wealth Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.6M in Q1 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Palacios Wealth Management held 20,078 shares of Pfizer worth $483K as of Q2 2026.
  • Palacios Wealth Management sold 484 Pfizer shares in Q2 2026, an estimated $12.7K.
  • Pfizer made up 0.29% of Palacios Wealth Management's portfolio in Q2 2026, its #47 holding.
  • Palacios Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Palacios Wealth Management's Pfizer position peaked at $25.6M in Q1 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Palacios Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.